US Stock MarketDetailed Quotes

Anebulo Pharmaceuticals (ANEB)

Watchlist
  • 0.3127
  • -0.0173-5.24%
15min DelayClose Aug 24 09:36 ET
12.75MMarket Cap-1.74P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Anebulo Pharmaceuticals (ANEB) Balance Sheet

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
Total Assets
-40.52%9.42M
+333.60%10.70M
+198.19%12.15M
+133.64%14.01M
+111.19%15.84M
-72.72%2.47M
-65.10%4.07M
-58.46%6.00M
-55.59%7.50M
-54.34%9.05M
-25.09%11.67M
-16.33%14.43M
-10.95%16.89M
-3.34%19.82M
-28.05%15.58M
+301.92%17.25M
+626.44%18.96M
--20.50M
--21.65M
--4.29M
Total Current Assets
-39.76%9.27M
+436.83%10.54M
+241.01%11.96M
+157.09%13.81M
+125.86%15.40M
-78.31%1.96M
-69.94%3.51M
-62.79%5.37M
-59.64%6.82M
-54.34%9.05M
-25.09%11.67M
-16.33%14.43M
-10.95%16.89M
-3.34%19.82M
-28.05%15.58M
+342.41%17.25M
+655.88%18.96M
--20.50M
--21.65M
--3.90M
Cash and Cash Equivalents & Short-Term Investments
-39.72%9.04M
+637.41%10.35M
+275.80%11.63M
+158.01%13.28M
+125.73%15.00M
-83.52%1.40M
-72.49%3.09M
-63.66%5.15M
-59.37%6.64M
-55.65%8.52M
-22.69%11.25M
-14.40%14.16M
-9.18%16.36M
+0.03%19.21M
-27.21%14.55M
+400.37%16.55M
+626.17%18.01M
--19.21M
--19.99M
--3.31M
-Cash and Cash Equivalents
-39.72%9.04M
+637.41%10.35M
+275.80%11.63M
+158.01%13.28M
+125.73%15.00M
-83.52%1.40M
-72.49%3.09M
-63.66%5.15M
-59.37%6.64M
-55.65%8.52M
-22.69%11.25M
-14.40%14.16M
-9.18%16.36M
+0.03%19.21M
-27.21%14.55M
+400.37%16.55M
+626.17%18.01M
--19.21M
--19.99M
--3.31M
Receivables
+84.62%56.78K
-96.00%9.83K
--73.22K
----
--30.76K
--245.36K
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
--23.07K
-Taxes Receivable
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--23.07K
-Due from Related Parties Current
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-Other Receivables
+84.62%56.78K
-96.00%9.83K
--73.22K
----
--30.76K
--245.36K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Prepaid Assets
-52.11%175.41K
-45.43%170.77K
-36.82%261.44K
+136.07%528.03K
+113.27%366.27K
-40.65%312.94K
-2.12%413.79K
-16.48%223.68K
-67.77%171.74K
-12.36%527.31K
-58.99%422.75K
-61.78%267.80K
-44.19%532.91K
-53.45%601.67K
-38.19%1.03M
--700.74K
+3209.24%954.88K
--1.29M
--1.67M
----
Other Current Assets
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--568.59K
Total Non-Current Assets
-66.74%148.23K
-67.22%165.67K
-67.60%183.11K
-67.90%200.55K
-34.88%445.73K
--505.43K
--565.12K
--624.82K
--684.52K
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--0.00
--0.00
--392.73K
Non-Current Deferred Assets
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--392.73K
Other Non-Current Assets
-66.74%148.23K
-67.22%165.67K
-67.60%183.11K
-67.90%200.55K
-34.88%445.73K
--505.43K
--565.12K
--624.82K
--684.52K
----
----
----
----
----
----
----
----
----
----
----
Total Liabilities
+69.05%1.49M
+69.32%963.82K
+87.15%487.69K
-45.95%546.03K
-13.30%878.80K
-20.56%569.23K
-75.62%260.58K
-32.24%1.01M
-26.15%1.01M
+2.63%716.56K
+108.53%1.07M
+1638.33%1.49M
+2647.88%1.37M
+14.89%698.18K
+112.11%512.53K
-99.38%85.78K
-98.50%49.94K
--607.71K
--241.63K
--13.73M
Total Current Liabilities
+69.05%1.49M
+69.32%963.82K
+87.15%487.69K
-45.95%546.03K
-13.30%878.80K
-20.56%569.23K
-75.62%260.58K
-32.24%1.01M
-26.15%1.01M
+2.63%716.56K
+108.53%1.07M
+1638.33%1.49M
+2647.88%1.37M
+14.89%698.18K
+112.11%512.53K
-70.74%85.78K
-85.88%49.94K
--607.71K
--241.63K
--293.17K
Payables
+73.66%554.86K
+140.95%607.54K
+43.31%224.18K
+11.08%427.58K
+0.26%319.52K
-55.45%252.14K
-70.74%156.43K
-32.58%384.92K
-8.04%318.68K
+8.11%565.95K
+40.36%534.55K
+585.55%570.90K
+706.99%346.55K
+6.01%523.47K
+246.06%380.83K
+1.52%83.28K
-49.16%42.94K
--493.82K
--110.05K
--82.03K
-Accounts Payable
+73.66%554.86K
+140.95%607.54K
+43.31%224.18K
+11.08%427.58K
+0.26%319.52K
-55.45%252.14K
-70.74%156.43K
-32.58%384.92K
-8.04%318.68K
+8.11%565.95K
+40.36%534.55K
+585.55%570.90K
+706.99%346.55K
+6.01%523.47K
+246.06%380.83K
+1.52%83.28K
-49.16%42.94K
--493.82K
--110.05K
--82.03K
Current Accrued Expenses
+66.42%930.78K
+12.36%356.28K
+153.00%263.51K
-81.06%118.45K
-19.51%559.28K
+110.53%317.08K
-80.50%104.16K
-32.04%625.40K
-32.26%694.88K
-13.79%150.61K
+305.65%534.26K
+36707.32%920.18K
+14554.96%1.03M
+53.40%174.71K
+0.09%131.70K
-98.82%2.50K
-88.32%7.00K
--113.89K
--131.59K
--211.14K
Total Non-Current Liabilities
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--0.00
--0.00
--13.43M
Derivative Product Liabilities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--10.46M
Convertible preferred securities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--2.98M
Total Equity
-46.96%7.94M
+412.83%9.74M
+205.78%11.66M
+170.04%13.46M
+130.64%14.96M
-77.21%1.90M
-64.04%3.81M
-61.48%4.99M
-58.19%6.49M
-56.42%8.33M
-29.64%10.60M
-24.60%12.94M
-17.97%15.52M
-3.90%19.12M
-29.63%15.07M
+281.89%17.16M
+2730.52%18.91M
--19.89M
--21.41M
---9.44M
Stockholders' Equity
-46.96%7.94M
+412.83%9.74M
+205.78%11.66M
+170.04%13.46M
+130.64%14.96M
-77.21%1.90M
-64.04%3.81M
-61.48%4.99M
-58.19%6.49M
-56.42%8.33M
-29.64%10.60M
-24.60%12.94M
-17.97%15.52M
-3.90%19.12M
-29.63%15.07M
+281.89%17.16M
+2730.52%18.91M
--19.89M
--21.41M
---9.44M
Capital Stock
+0.00%41.09K
+58.43%41.09K
+58.43%41.09K
+58.43%41.09K
+58.43%41.09K
+1.17%25.93K
+1.17%25.93K
+1.17%25.93K
+1.17%25.93K
+0.00%25.63K
+9.81%25.63K
+9.81%25.63K
+9.81%25.63K
+9.81%25.63K
+0.00%23.35K
+79.81%23.35K
+79.81%23.35K
--23.35K
--23.35K
--12.98K
-Common Stock
+0.00%41.09K
+58.43%41.09K
+58.43%41.09K
+58.43%41.09K
+58.43%41.09K
+1.17%25.93K
+1.17%25.93K
+1.17%25.93K
+1.17%25.93K
+0.00%25.63K
+9.81%25.63K
+9.81%25.63K
+9.81%25.63K
+9.81%25.63K
+0.00%23.35K
+79.81%23.35K
+79.81%23.35K
--23.35K
--23.35K
--12.98K
-Preferred Stock
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
Additional Paid-In Capital
+1.12%85.94M
+23.41%85.74M
+23.58%85.51M
+23.40%85.17M
+23.42%84.99M
+2.19%69.48M
+2.08%69.19M
+2.06%69.01M
+2.17%68.86M
+1.21%67.99M
+12.00%67.78M
+12.17%67.62M
+12.03%67.40M
+11.83%67.17M
+0.80%60.51M
+72076.69%60.29M
+166463.45%60.16M
--60.07M
--60.03M
--83.53K
Retained Earnings
-11.39%-78.05M
-12.49%-76.05M
-12.97%-73.89M
-12.01%-71.74M
-12.29%-70.07M
-13.27%-67.60M
-14.34%-65.40M
-17.09%-64.05M
-20.21%-62.40M
-24.13%-59.68M
-25.80%-57.20M
-26.79%-54.71M
-25.78%-51.91M
-19.61%-48.08M
-17.66%-45.47M
-352.64%-43.15M
-5272.92%-41.27M
---40.20M
---38.64M
---9.53M
Deadline
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
2026/Q22026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q3
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +15.93%
Sample Name
Sample Code
 +10.91%
Sample Name
Sample Code
 +10.15%
4
United Sts Brent Oil Fd Lp Unit
BNO
+8.33%
5
United States Oil Fund LP
USO
+5.97%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +6.80%
Sample Name
Sample Code
 +5.98%
Sample Name
Sample Code
 +5.76%
4
KE Holdings
BEKE
+5.10%
5
H World Group
HTHT
+4.36%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On August 24 (U.S. Eastern Time), U.S. Treasury Secretary Bessent announced "unprecedented" economic actions against Iran, aiming to sever i Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -